Baker Botts L.L.P. advises life sciences clients on the IP, litigation, and corporate transactional matters associated with bringing pharmaceutical products, medical devices, and research tools to market. The firm also supports clients on business development initiatives and corporate transactions within the sector, including identifying and evaluating potential investment targets, mergers, and acquisitions. Steve Lendaris, firmwide life sciences sector chair and based in New York, advises on a range of biotechnology-related IP matters, including evaluating third-party patents ahead of product launches and developing patent filing strategies for new therapeutic approaches.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The Baker Botts team has been very responsive to our needs. They have taken complex problems (e.g. IP) and worked through them to provide solid guidance and solutions.’
‘Their ability to quickly understand/comprehend complex problems and offer thoughtful solutions.'
- 'Their proactive nature – providing unsolicited recommendations for problems and issues that need to be addressed.’
Key clients
- Agni Bio, Inc.
- Alga Biosciences
- Antipodean Pharmaceuticals, Inc. and MitoQ Ltd
- Assertio Holdings, Inc.
- Columbia University
- Editas Medicine
- Eikon Therapeutics, Inc.
- FUJIFILM Cellular Dynamics, Inc. (FCDI)
- Genentech / Roche
- GRAIL, Inc.
- Kanvas Biosciences
- Lazarus3D, Inc.
- Memorial Sloan Kettering Cancer Center
- Merck & Co., Inc.
- National Associate of Boards of Pharmacy
- Novartis International AG / Novartis Pharmaceuticals
- Octagos Acquisition, LLC / Octagos Health, Inc.
- OncoNano Medicine, Inc.
- Penumbra, Inc
- Pharmacosmos A/S
Work highlights
Handles a wide variety of diligence and prosecution matters for Genentech, a leading biotechnology company and member of the Roche family of companies.
Represents Sun Pharmaceuticals and Taro Pharmaceuticals in two major antitrust matters.
Serves as lead M&A antitrust counsel for UnitedHealth Group, advising on major transactions across its enterprise, including health plans, care delivery, PBM services, and healthcare technology.
Practice head
Steve Lendaris
Other key lawyers
Matthew Avery; Sandra Lee